A placebo-controlled, randomized phase II study of conatumumab (C) or AMG 479 (A) or placebo (P) plus gemcitabine (G) in patients (pts) with metastatic pancreatic cancer (mPC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Kindler, HL
  • Richards, DA
  • Stephenson, J
  • Garbo, LE
  • Lima, CS Rocha
  • Safran, H
  • Wiezorek, JS
  • Feigal, EG
  • Bray, Steven
  • Fuchs, C

publication date

  • May 20, 2010